Profil
Göran Tornling currently works at AcuCort AB, as Independent Director from 2021, Karolinska Institutet, as Associate Professor, Biolipox AB, as Chief Medical Officer & Vice President from 2006, and AnaMar AB, as Chief Medical Officer.
Dr. Tornling also formerly worked at AstraZeneca R&D Boston, Inc., as Director-Medical Science.
Dr. Tornling received his doctorate degree from Karolinska Institutet.
Aktive Positionen von Göran Tornling
| Unternehmen | Position | Beginn |
|---|---|---|
| ACUCORT AB | Direktor/Vorstandsmitglied | 01.01.2021 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2006 |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Göran Tornling
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Corporate Officer/Principal | - |
Ausbildung von Göran Tornling
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Health Technology |
AnaMar AB
AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
















